Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.80
+0.08001.04%
Post-market: 7.800.00000.00%18:14 EDT
Volume:20.12K
Turnover:156.55K
Market Cap:53.01M
PE:-0.68
High:8.02
Open:7.60
Low:7.54
Close:7.72
Loading ...
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2021

Major Issues Report

8-K - Current report
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Major Issues Report

8-K - Current report
Dec 09, 2020

Major Issues Report

8-K - Current report